Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TARP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VDR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
THOC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FASTKD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPBD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UTP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XRCC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBAP2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPNE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on